BIOMAT Database Logo BIOMAT Database Logo

Chemokine IP-10 expression in cultured human keratinocytes. 1998

D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Department of Dermatology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands. dm.boorsma@azvu.nl

IP-10, a member of the CXC family of chemokines, is considered to play an important role in inflammation via its T-cell chemotactic and adhesion-promoting properties. Elevated IP-10 levels in the epidermis of psoriasis, delayed-type hypersensitivity reactions, cutaneous T-cell lymphoma and fixed drug eruptions prompted us to study its expression in keratinocytes. IP-10 mRNA could be detected using the sensitive RT-PCR method, but not by Northern blotting in RNA preparations from unstimulated normal cultured keratinocytes, indicating a low steady-state level of IP-10 mRNA. Upon stimulation with IFN-gamma, IP-10 mRNA was found to accumulate in high amounts in a time- and dose-dependent manner. Superexpression was found with the combination of IFN-gamma and TNF-alpha or IL-1, although these latter cytokines by themselves did not induce accumulation of IP-10 mRNA. Nuclear run-on experiments performed to investigate the regulation of IP-10 mRNA expression, showed a very high constitutive transcriptional activity of the IP-10 gene in unstimulated keratinocytes, which was not affected by stimulation with IFN-gamma, TNF-alpha, or a combination of IFN-gamma and TNF-alpha. Protein kinase C (PKC) was shown to be involved in IP-10 mRNA expression since the PKC inhibitor H7 decreased IP-10 mRNA accumulation. A protein was isolated from culture supernatants of stimulated keratinocytes using HPLC techniques and, by sequence analysis, was found to be identical to IP-10. The dynamics of secretion of IP-10 protein as monitored by ELISA was shown to parallel the mRNA expression.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008297 Male Males
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Expression of IP-10 chemokine is regulated by pro-inflammatory cytokines in cultured hepatocytes.
September 2007, Iranian journal of allergy, asthma, and immunology,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Vascular endothelial growth factor induces IP-10 chemokine expression.
March 2002, Biochemical and biophysical research communications,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-gamma-inducible protein (gamma-IP-10) gene expression in cultured normal human keratinocytes.
January 1994, Archives of dermatological research,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Expression of CXC chemokine IP-10 in testicular germ cell tumours.
May 2002, The Journal of pathology,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Expression of CXC chemokine IP-10 in patients with chronic hepatitis B.
February 2008, Hepatobiliary & pancreatic diseases international : HBPD INT,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
[Cryoglobulinemia and the α-chemokine IP-10].
January 2014, La Clinica terapeutica,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Structure of mouse IP-10, a chemokine.
June 2008, Acta crystallographica. Section D, Biological crystallography,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
The Th1 chemokine IP-10 in Systemic sclerosis.
January 2014, La Clinica terapeutica,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes.
January 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
D M Boorsma, and J Flier, and S Sampat, and C Ottevanger, and P de Haan, and L Hooft, and R Willemze, and C P Tensen, and T J Stoof
Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.
November 2001, Circulation,
Copied contents to your clipboard!